Get started
Author

Jason M. Uslaner

Observed names: J. Uslaner, J.M. Uslaner, Jason M Uslaner, Jason Uslaner, Uslaner JM, Uslaner, Jason
Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), University of California, Los Angeles, Oregon Health & Science University, University of Michigan, WuXi AppTec (China), Hammersmith Medicines Research, Addex Therapeutics (Switzerland), MSD (Belgium)
ORCID: 0000-0002-8952-5940
Observed ORCID: 0000-0002-8952-5940
OpenAlex ID: A5073747755
Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus
2009 · Jason M. Uslaner, Sophie Parmentier-Batteur, et al. · Neuropharmacology · 191
The attribution of incentive salience to a stimulus that signals an intravenous injection of cocaine
2006 · Jason M. Uslaner, Martin J. Acerbo, et al. · Behavioural Brain Research · 167
Methamphetamine‐induced structural plasticity in the dorsal striatum
2007 · Jakub P. Jedynak, Jason M. Uslaner, et al. · European Journal of Neuroscience · 152
The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
2011 · P.H. Hutson, E.N. Finger, et al. · Neuropharmacology · 143
Subthalamic nucleus lesions increase impulsive action and decrease impulsive choice − mediation by enhanced incentive motivation?
2006 · Jason M. Uslaner, Terry E. Robinson · European Journal of Neuroscience · 131
PDF
Amphetamine and cocaine induce different patterns of c‐fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context
2001 · Jason Uslaner, Aldo Badiani, et al. · European Journal of Neuroscience · 116
PDF
Environmental Novelty Differentially Affects c-fosmRNA Expression Induced by Amphetamine or Cocaine in Subregions of the Bed Nucleus of the Stria Terminalis and Amygdala
2001 · Heidi E. W. Day, Aldo Badiani, et al. · Journal of Neuroscience · 109
PDF
Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens
2001 · Jason Uslaner, Aldo Badiani, et al. · Brain Research · 104
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
2013 · Anthony L Gotter, Christopher J Winrow, et al. · BMC Neuroscience · 97
PDF
Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
2013 · Jason M. Uslaner, Spencer J. Tye, et al. · Science Translational Medicine · 91
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target
2013 · Sophie Parmentier-Batteur, Peter H. Hutson, et al. · Neuropharmacology · 91
Association of Depressive Symptoms During Abstinence With the Subjective High Produced by Cocaine
1999 · Jason Uslaner, Ari Kalechstein, et al. · American Journal of Psychiatry · 86
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
2012 · Sean M. Smith, Jason M. Uslaner, et al. · Neuropharmacology · 85
The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors
2010 · Sean M Smith, Jason M Uslaner, et al. · The Open Medicinal Chemistry Journal · 84
The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine
2008 · Sean M. Smith, Jason M. Uslaner, et al. · Journal of Pharmacology and Experimental Therapeutics · 84
MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy
2020 · Xiaohai Wang, Wenping Li, et al. · Journal of Pharmacology and Experimental Therapeutics · 79
PDF
MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?
2010 · Joshua D. Vardigan, Sarah L. Huszar, et al. · Pharmacology Biochemistry and Behavior · 77
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure
2009 · Christopher J. Winrow, Keith Q. Tanis, et al. · Neuropharmacology · 75
The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque
2012 · Jason M. Uslaner, Donnie Eddins, et al. · Psychopharmacology · 71
Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
2014 · Mikhail Kalinichev, Emmanuel Le Poul, et al. · Journal of Pharmacology and Experimental Therapeutics · 70
PDF
The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys
2015 · Henry S. Lange, Christopher E. Cannon, et al. · Journal of Pharmacology and Experimental Therapeutics · 68
Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
2015 · William D. Shipe, Steven S. Sharik, et al. · Journal of Medicinal Chemistry · 63
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration
2010 · Sophie Parmentier-Batteur, Julie A. OBrien, et al. · Neuropharmacology · 63
The Influence of Subthalamic Nucleus Lesions on Sign-Tracking to Stimuli Paired with Food and Drug Rewards: Facilitation of Incentive Salience Attribution?
2007 · Jason M Uslaner, James M Dell'Orco, et al. · Neuropsychopharmacology · 61
Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey
2014 · Joshua D. Vardigan, Christopher E. Cannon, et al. · Psychopharmacology · 59
Works count: 110
Citation count: 3,922
H-index: 39
I10-index: 68
Year
Topic
Type